Free Trial

Vor Biopharma (VOR) Earnings Date, Estimates & Call Transcripts

Vor Biopharma logo
$15.52 +0.81 (+5.51%)
Closing price 04:00 PM Eastern
Extended Trading
$15.38 -0.14 (-0.87%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vor Biopharma Earnings Summary

Vor Biopharma announced Q2 2025 earnings on August 12, 2025, reporting an EPS of -$43.60, which missed analysts' consensus estimates of -$11.40 by $32.20. With a trailing EPS of -$386.83, Vor Biopharma's earnings are expected to decrease next year, from ($3.25) to ($3.61) per share.

Consensus EPS
(Aug. 12)
-$11.40
Actual EPS
(Aug. 12)
-$43.60 Missed By -$32.20
Get Vor Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vor Biopharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

VOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Vor Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.25-$0.88-$1.07
Q2 20262-$1.43-$0.94-$1.19
Q3 20262-$1.02-$0.93-$0.98
Q4 20262-$1.10-$1.08-$1.09

Vor Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025-$11.40-$43.60 -$32.20-$12.56--
11/7/2024--$8.00-$8.00--$0.40--
8/8/2024--$8.20-$8.20--$0.41--
5/9/2024Q1 2024-$7.40-$9.00 -$1.60-$0.45--

Data powered by Fiscal.ai.

Vor Biopharma Earnings - Frequently Asked Questions

Vor Biopharma (NASDAQ:VOR) last announced its quarterly earning data on Tuesday, August 12, 2025. Learn more on VOR's earnings history.

In the previous quarter, Vor Biopharma (NASDAQ:VOR) missed the analysts' consensus estimate of ($11.40) by $32.20 with a reported earnings per share (EPS) of ($43.60). Learn more on analysts' earnings estimate vs. VOR's actual earnings.

Vor Biopharma's earnings are expected to decrease from ($3.25) per share to ($3.61) per share in the next year.


This page (NASDAQ:VOR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners